Stay updated on Dolutegravir Plus NRTIs in HIV-2 Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T16:16:10.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T10:02:54.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T04:54:44.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-23T02:16:20.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:19:38.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding a clinical trial for HIV-2 treatment, including detailed eligibility criteria and study procedures. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    41%
    Check dated 2025-04-16T20:31:29.000Z thumbnail image

Stay in the know with updates to Dolutegravir Plus NRTIs in HIV-2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.